VSTM Stock Summary and Trading Ideas (Verastem | NASDAQ:VSTM)

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem trades on the NASDAQ stock market under the symbol VSTM.

As of March 11, 2026, VSTM stock price declined to $6.36 with 165,955 million shares trading.

VSTM has a beta of 0.56, meaning it tends to be less sensitive to market movements. VSTM has a correlation of 0.01 to the broad based SPY ETF.

VSTM has a market cap of $479.03 million. This is considered a Small Cap stock.

Last quarter Verastem reported $18 million in Revenue and -$.48 earnings per share. This beat revenue expectation by $429,572 and exceeded earnings estimates by $.01.

In the last 3 years, VSTM traded as high as $15.18 and as low as $2.10.

The top ETF exchange traded funds that VSTM belongs to (by Net Assets): VTI, XBI, IWM, VXF, FESM.

VSTM has underperformed the market in the last year with a return of -10.7%, while the SPY ETF gained +22.2%. In the last 3 month period, VSTM fell short of the market, returning -36.5%, while SPY returned -1.1%. However, in the most recent 2 weeks VSTM has outperformed the stock market by returning +7.8%, while SPY returned -1.4%.

VSTM support price is $6.09 and resistance is $6.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VSTM shares will trade within this expected range on the day.